de Jong IJ - Search Results

1

β3-Adrenoceptor-mediated relaxation of rat and human urinary bladder: roles of BKCa channels and Rho kinase.

Cernecka H, Kersten K, Maarsingh H, Elzinga CR, de Jong IJ, Korstanje C, Michel MC, Schmidt M. Cernecka H, et al. Among authors: de jong ij. Naunyn Schmiedebergs Arch Pharmacol. 2015 Jul;388(7):749-59. doi: 10.1007/s00210-015-1128-z. Epub 2015 May 9. Naunyn Schmiedebergs Arch Pharmacol. 2015. PMID: 25956403 Free PMC article.

2

An update of radiolabeled bombesin analogs for gastrin-releasing peptide receptor targeting.

Yu Z, Ananias HJ, Carlucci G, Hoving HD, Helfrich W, Dierckx RA, Wang F, de Jong IJ, Elsinga PH. Yu Z, et al. Among authors: de jong ij. Curr Pharm Des. 2013;19(18):3329-41. doi: 10.2174/1381612811319180015. Curr Pharm Des. 2013. PMID: 23431995 Review.

3

Urinary bladder carcinoma: impact of smoking, age and its clinico-pathological spectrum.

Joshi HN, Makaju R, Karmacharya A, Karmacharya RM, Shrestha B, Shrestha R, de Jong IJ, Shrestha RK. Joshi HN, et al. Among authors: de jong ij. Kathmandu Univ Med J (KUMJ). 2013 Oct-Dec;11(44):292-5. doi: 10.3126/kumj.v11i4.12524. Kathmandu Univ Med J (KUMJ). 2013. PMID: 24899322

4

Inhibition of tyrosine kinase receptor signaling attenuates fibrogenesis in an ex vivo model of human renal fibrosis.

Bigaeva E, Stribos EGD, Mutsaers HAM, Piersma B, Leliveld AM, de Jong IJ, Bank RA, Seelen MA, van Goor H, Wollin L, Olinga P, Boersema M. Bigaeva E, et al. Among authors: de jong ij. Am J Physiol Renal Physiol. 2020 Jan 1;318(1):F117-F134. doi: 10.1152/ajprenal.00108.2019. Epub 2019 Nov 18. Am J Physiol Renal Physiol. 2020. PMID: 31736352 Free article.

5

CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy.

Domanska UM, Timmer-Bosscha H, Nagengast WB, Oude Munnink TH, Kruizinga RC, Ananias HJ, Kliphuis NM, Huls G, De Vries EG, de Jong IJ, Walenkamp AM. Domanska UM, et al. Among authors: de jong ij, de vries eg. Neoplasia. 2012 Aug;14(8):709-18. doi: 10.1593/neo.12324. Neoplasia. 2012. PMID: 22952424 Free PMC article.

6

Visualization of prostate cancer with 11C-choline positron emission tomography.

de Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ. de Jong IJ, et al. Eur Urol. 2002 Jul;42(1):18-23. doi: 10.1016/s0302-2838(02)00129-x. Eur Urol. 2002. PMID: 12121724

7

Visualisation of bladder cancer using (11)C-choline PET: first clinical experience.

de Jong IJ, Pruim J, Elsinga PH, Jongen MM, Mensink HJ, Vaalburg W. de Jong IJ, et al. Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):1283-8. doi: 10.1007/s00259-002-0881-7. Epub 2002 Jul 27. Eur J Nucl Med Mol Imaging. 2002. PMID: 12271408 Clinical Trial.

8

Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.

de Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ. de Jong IJ, et al. J Nucl Med. 2003 Mar;44(3):331-5. J Nucl Med. 2003. PMID: 12620996 Free article.

9

11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer.

de Jong IJ, Pruim J, Elsinga PH, Vaalburg W, Mensink HJ. de Jong IJ, et al. Eur Urol. 2003 Jul;44(1):32-8; discussion 38-9. doi: 10.1016/s0302-2838(03)00207-0. Eur Urol. 2003. PMID: 12814672 Clinical Trial.

10

Nuclear imaging of prostate cancer with gastrin-releasing-peptide-receptor targeted radiopharmaceuticals.

Ananias HJ, de Jong IJ, Dierckx RA, van de Wiele C, Helfrich W, Elsinga PH. Ananias HJ, et al. Among authors: de jong ij. Curr Pharm Des. 2008;14(28):3033-47. doi: 10.2174/138161208786404335. Curr Pharm Des. 2008. PMID: 18991717 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page